KG13

N/A

Report date: 2022/11/16 17:18:56
NME

Base Information

Drug NameKG13
Drug Alias NameKG-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUc San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesUc San Francisco
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A